Short and long latency afferent inhibition in Parkinson's disease

Brain

Volumn 126, Issue 8, 2003, Pages 1883-1894

  Sailer, Alexandra ^a   Molnar, Gregory F ^a   Paradiso, Guillermo ^a   Gunraj, Carolyn A ^a   Lang, Anthony E ^a   Chen, Robert ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Magnetic stimulation; Motor cortex; Nerve stimulation; Parkinson's disease

Indexed keywords

AMANTADINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; LONG LATENCY AFFERENT INHIBITION; MALE; MEDIAN NERVE; MOTOR CORTEX; MOTOR DYSFUNCTION; NERVE STIMULATION; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SENSORY DYSFUNCTION; SENSORY NERVE CONDUCTION; SENSORY STIMULATION; SHORT LATENCY AFFERENT INHIBITION; SIDE EFFECT; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0043268768     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg183     Document Type: Article

References (42)

1. Abbruzzese G, Vische M, Ratto S, Abbruzzese M, Favale E. Assessment of motor neuron excitability in parkinsonian rigidity by the F wave. J Neurol 1985; 232: 246-9.
2. Abbruzzese G, Marchese R, Buccolieri A, Gasparetto B, Trompetto C. Abnormalities of sensorimotor integration in focal dystonia: a transcranial magnetic stimulation study. Brain 2001; 124: 537-45.
3. Allison T, McCarthy G, Wood CC. The relationship between human long-latency somatosensory evoked potentials recorded from the cortical surface and from the scalp. Electroencephalogr Clin Neurophysiol 1992; 84: 301-14.
4. Aosaki T, Graybiel AM, Kimura M. Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. Science 1994; 265: 412-5.
5. Barbeau A, Mars H, Gillo-Joffroy L. Adverse clinical side effects of levodopa therapy. In: McDowell F, Markham C, editors. Recent advances in Parkinson's disease. Philadelphia: F. A. Davis; 1971. p. 203-37.
6. Berardelli A, Dick JP, Rothwell JC, Day BL, Marsden CD. Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1986; 49: 1273-9.
7. Berardelli A, Rona S, Inghilleri M, Manfredi M. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain 1996; 119: 71-7.
8. Boecker H, Ceballos-Baumann A, Bartenstein P, Weindl A, Siebner HR, Fassbender T, et al. Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET. Brain 1999; 122: 1651-65.
9. Bronte-Stewart HM, Minn AY, Rodrigues K, Buckley EL, Nashner LM. Postural instability in idiopathic Parkinson's disease: the role of medication and unilateral pallidotomy. Brain 2002; 125: 2100-2114.
10. Brown LL, Schneider JS, Lidsky TI. Sensory and cognitive functions of the basal ganglia. Curr Opin Neurobiol 1997; 7: 157-63.
11. Chen R, Corwell B, Hallett M. Modulation of motor cortex excitability by median nerve and digit stimulation. Exp Brain Res 1999; 129: 77-86.
12. Classen J, Steinfelder B, Liepert J, Stefan K, Celnik P, Cohen LG, et al. Cutaneomotor integration in humans is somatotopically organized at various levels of the nervous system and is task dependent. Exp Brain Res 2000; 130: 48-59.
13. Delwaide PJ, Olivier E. Conditioning transcranial cortical stimulation (TCCS) by exteroceptive stimulation in Parkinsonian patients. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH, editors. Parkinson's disease: anatomy, pathology and therapy. Advances in neurology, Vol. 53. New York: Raven Press; 1990. p. 175-81.
14. Demirci M, Grill S, McShane L, Hallett M. A mismatch between kinesthetic and visual perception in Parkinson's disease. Ann Neurol 1997; 41: 781-788.
15. Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Di Giovanni S, Zito G, et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 2000; 135: 455-461.
16. Di Lazzaro V, Oliviero A, Tonali P, Marra C, Daniele A, Profice P, et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 2002; 59: 392-7.
17. Forss N, Hari R, Salmelin R, Ahonen A, Hamalainen M, Kajola M, et al. Activation of the human posterior parietal cortex by median nerve stimulation. Exp Brain Res 1994; 99: 309-15.
18. Hari R, Reinikainen K, Kaukoranta E, Hamalainen M, Ilmoniemi R, Penttinen A, et al. Somatosensory evoked cerebral magnetic fields from SI and SII in man. Electroencephalogr Clin Neurophysiol 1984; 57: 254-63.
19. Henderson JM, Carpenter K, Cartwright H, Halliday GM. Degeneration of the centre median-parafascicular complex in Parkinson's disease. Ann Neurol 2000; 47: 345-52.
20. Hillen ME, Sage JI. Nonmotor fluctuations in patients with Parkinson's disease. Neurology 1996; 47: 1180-3.
21. Jobst EE, Melnick ME, Byl NN, Dowling GA, Aminoff MJ. Sensory perception in Parkinson disease. Arch Neurol 1997; 54: 450-4.
22. Kimura J. Assessment of individual nerves. In: Kimura J, editor. Electrodiagnosis in diseases of nerve and muscle: principles and practice. Philadelphia (PA): F. A. Davis; 1989. p. 103-11.
23. Klockgether T, Borutta M, Rapp H, Spieker S, Dichgans J. A defect of kinesthesia in Parkinson's disease. Mov Disord 1995; 10: 460-5.
24. Koller WC. Sensory symptoms in Parkinson's disease. Neurology 1984; 34: 957-9.
25. Levy R, Dostrovsky JO, Lang AE, Sime E, Hutchison WD, Lozano AM. Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease. J Neurophysiol 2001; 86: 249-60.
26. Lewis GN, Byblow WD. Altered sensorimotor integration in Parkinson's disease. Brain 2002; 125: 2089-99.
27. Moore AP. Impaired sensorimotor integration in parkinsonism and dyskinesia: a role for corollary discharges? J Neurol Neurosurg Psychiatry 1987; 50: 544-52.
28. O'Suilleabhain P, Bullard J, Dewey RB. Proprioception in Parkinson's disease is acutely depressed by dopaminergic medications. J Neurol Neurosurg Psychiatry 2001; 71: 607-10.
29. Onofrj M, Ghilardi MF, Basciani M, Martinez-Tica J, Glover A. Attenuation of the early anterior negativity of median nerve somatosensory evoked potential in the MPTP-treated monkey. Neurophysiol Clin 1990; 20: 283-93.
30. Pallis C. Parkinsonism: natural history and clinical features. Br Med J 1971; 3: 683-90.
31. Rocchi L, Chiari L, Horak FB. Effects of deep brain stimulation and levodopa on postural sway in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 267-74.
32. Rossini PM, Traversa R, Boccasena P, Martino G, Passarelli F, Pacifici L, et al. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components. Neurology 1993; 43: 2495-500.
33. Rothblat DS, Schneider JS. Response of caudate neurons to stimulation of intrinsic and peripheral afferents in normal, symptomatic, and recovered MPTP-treated cats. J Neurosci 1993; 13: 4372-8.
34. Sailer A, Molnar GF, Cunic DI, Chen R. Effects of peripheral sensory input on cortical inhibition in humans. J Physiol 2002; 544: 617-29.
35. Schneider JS, Diamond SG, Markham CH. Parkinson's disease: sensory and motor problems in arms and hands. Neurology 1987; 37: 951-6.
36. Seiss E, Praamstra P, Hesse CW, Rickards H. Proprioceptive sensory function in Parkinson's disease and Huntington's disease: evidence from proprioception-related EEG potentials. Exp Brain Res 2003; 148: 308-19.
37. Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology 1976; 26: 423-9.
38. Tamburin S, Manganotti P, Zanette G, Fiaschi A. Cutaneomotor integration in human hand motor areas: somatotopic effect and interaction of afferents. Exp Brain Res 2001; 141: 232-41.
39. Tamburin S, Manganotti P, Marzi CA, Fiaschi A, Zanette G. Abnormal somatotopic arrangement of sensorimotor interactions in dystonic patients. Brain 2002; 125: 2719-30.
40. Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A, et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 2000; 523: 503-13.
41. Ulivelli M, Rossi S, Pasqualetti P, Rossini PM, Ghiglieri O, Passero S, et al. Time course of frontal somatosensory evoked potentials. Relation to L-dopa plasma levels and motor performance in PD. Neurology 1999; 53: 1451-7.
42. Zia S, Cody F, O'Boyle D. Joint position sense is impaired by Parkinson's disease. Ann Neurol 2000; 47: 218-28.